One way is that relevant ZBTB7A mutations in t (8;21) AML can contribute to perturbed myeloid differentiation with blockage of the monocytic differentiation to promote granulopoiesis; they can also disturb the differentiation of HSCs and HSPCs. Here, ZBTB7A is linked to acute myeloid leukemia.